Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 10, 2018
MediWound Reports First Quarter 2018 Financial Results
YAVNE, Israel, May 10, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 10, 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
INDIANAPOLIS and REDWOOD CITY, Calif., May 10, 2018 /PRNewswire/ -- Eli Lilly and Company (LLY) and ARMO BioSciences, Inc. (ARMO) today announced a definitive agreement for ...
May 10, 2018
HTG Molecular Diagnostics to Feature Its HTG EdgeSeq Precision Immuno-Oncology Panel at Booth #4113 at the American Society of Clinical Oncology (ASCO) Conference in June 2018
TUCSON, Ariz., May 10, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, ...
May 10, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
SAN DIEGO, May 10, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Amit D. Munshi, President and Chief Executive Officer, will present at the following ...
May 10, 2018
Theravance Biopharma to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
DUBLIN, May 10, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer will participate in a fireside ...
May 10, 2018
Bellerophon Provides Business Update and Reports First Quarter 2018 Financial Results
WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and ...
May 10, 2018
Krystal Biotech Announces Dosing of First Patient in the Phase 1/2 trial of KB103, a First-in-Class Topical Gene Therapy for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, May 10, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological ...
May 10, 2018
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
VANCOUVER , May 10, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
May 10, 2018
Aptose Reports Results for the First Quarter Ended March 31, 2018
SAN DIEGO and TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
May 10, 2018
Rockwell Medical Reports First Quarter 2018 Results
WIXOM, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated specialty pharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney ...
May 10, 2018
Pernix Therapeutics Reports First Quarter 2018 Financial Results
MORRISTOWN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today its financial results for the three ...
May 10, 2018
HTG Molecular Diagnostics Reports First Quarter 2018 Results
TUCSON, Ariz., May 10, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, ...
May 10, 2018
BioDelivery Sciences Reports Positive First Quarter 2018 Financial Results and Provides Corporate Update
RALEIGH, N.C., May 10, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the first quarter ended March 31, 2018 ...
May 10, 2018
Pfenex Reports First Quarter 2018 Results and Provides Business Update
SAN DIEGO, May 10, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® ...
May 10, 2018
Neovasc Announces Results for the First Quarter 2018
VANCOUVER , May 10, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
May 10, 2018
BioLife Solutions Announces First Quarter 2018 Financial Results
BOTHELL, Wash., May 10, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic ...
May 10, 2018
BioTime Reports First Quarter Results and Recent Corporate Accomplishments
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today reported financial results for the first quarter ended March 31, ...
May 10, 2018
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and ...
May 10, 2018
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
May 10, 2018
Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on May 15, 2018
CRANBURY, N.J., May 10, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2018 operating results on Tuesday, May ...
Page 52 of 127